[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 319
Citations 0
News From the Food and Drug Administration
June 16, 2015

Surgical Sealant Gets the Nod

JAMA. 2015;313(23):2312. doi:10.1001/jama.2015.6323

The first spray-dried fibrin sealant used to control bleeding during surgery has gained FDA approval.

Raplixa is a biological product that contains fibrinogen and thrombin, 2 proteins found in human plasma. The sealant dissolves in blood, triggering a reaction between those proteins, which forms blood clots to stop small blood vessels from bleeding when standard techniques such as suture, ligature, or cautery are ineffective or impractical (http://1.usa.gov/1HVGQSd).

First Page Preview View Large
First page PDF preview
First page PDF preview
×